<div data-server-rendered="true" id="__nuxt"><div id="__layout"><div class="outer-container"><div class="content-container"> <div class="answer_container" style="min-height:calc(100vh - 54px);" data-v-0eba195e=""><div class="content_outer_container" data-v-0eba195e=""><div class="share_preview_container" data-v-0eba195e=""><div class="dialog_list" data-v-0eba195e=""><div class="dialog_item" data-v-0eba195e=""><div class="dialog_question fir_dialog_question" data-v-0eba195e=""><div class="question_con" data-v-0eba195e=""><h1 class="fir_question_content" data-v-0eba195e="">
                                    Why did InnVenture's operating expenses surge in Q3 2024?
                                </h1> <div class="user_slot" data-v-0eba195e=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/default_aime_user.ec532c9.png" alt="user" class="avatar" data-v-0eba195e=""> <span class="user_desction" data-v-0eba195e="">
                                        
                                        5/9/2025 12:29am
                                    </span></div></div></div> <div class="seo-text-answer" data-v-0eba195e="">Invivyd's operating expenses did not surge in Q3 2024. In fact, the company experienced a significant reduction in its operating costs and expenses in Q4 2024, with preliminary total operating costs and expenses amounting to approximately $32 million, which represents a 55% reduction compared to the $71.6 million reported in Q3 2024. This reduction was primarily driven by a decrease in manufacturing expenses, which allowed the company to achieve a net product revenue of $13.8 million for Q4 2024, marking a 48% growth over the $9.3 million reported in Q3 2024.</div> <div class="dialog_answer" data-v-0eba195e=""><div class="dialog_content" data-v-0eba195e=""><div class="answer_content" data-v-0eba195e=""></div></div></div></div></div> </div></div></div> </div> <div class="extra-module" data-v-261d488f=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/recommend-logo.4f9ccc8.png" alt="right-logo" fetchpriority="high" class="recommend-logo-img" data-v-261d488f=""> <div class="recommend-part" data-v-7790c618="" data-v-261d488f=""><div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/screener-recommend-icon.b007ca8.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime finds your next big stock</span></div> </div> <div class="recommend-query-card" data-v-8359219a="" data-v-7790c618=""><div class="title" data-v-8359219a=""><img src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/img/stock-recommend-icon.77f1c78.svg" alt="icon" data-v-8359219a=""> <span data-v-8359219a="">Aime powers your decisions</span></div> </div></div> </div> <div class="container-mask" style="display:none;"></div></div></div></div><script>window.__NUXT__=(function(a,b,c,d,e,f,g,h,i,j,k,l,m,n,o,p,q,r,s,t,u,v,w,x,y,z,A,B,C,D,E,F,G,H,I,J,K,L,M,N,O,P,Q,R,S,T,U,V,W,X,Y,Z,_,$,aa,ab,ac,ad,ae,af,ag,ah,ai,aj,ak,al){return {layout:"default",data:[{noData:b,currentQuestion:d,textDescription:C,comeFrom:"AInvestShareLink",events:[],answerSource:i}],fetch:{},error:j,state:{sharePreviewModule:{loadJgySuccess:f,dialogRenderList:[{originAnswer:{input_media_info:[],session_round:1,agent_id:a,output_media_info:[],task_id:a,language:a,source:i,cache_builder:a,reply_action:"Answer",execute_mode:u,event_refresh_answer:a,param:"{\"entity_info\":{},\"add_info\":{\"ori_question\":\"Why did InnVenture's operating expenses surge in Q3 2024?\"},\"event_list\":[],\"client_ip\":\"\",\"question\":\"Why did InnVenture's operating expenses surge in Q3 2024?\",\"user_id\":\"dp14504375\",\"user_name\":\"\",\"trace_id\":\"64aa6a5a-0a36-4ee7-a8b1-67237e8bd6a4\",\"session_id\":\"64aa6a5a-0a36-4ee7-a8b1-67237e8bd6a4\",\"source\":\"ths_ainvest_lite_web\",\"input_type\":\"typewrite\"}",agent_info:[{info_type:"search",raw_data:{number:D,title:E,summary:F,full_summary:"Preliminary Q4 2024 PEMGARDA™ (pemivibart) net product revenue of $13.8 million, 48% growth over Q3 2024 net product revenue of $9.3 million Preliminary Q4 2024 total operating costs and expenses of approximately $32 million, 55% reduction compared to Q3 2024 operating costs and expenses of $71.6 million Preliminary ending 2024 cash and cash equivalents of $69.3 million and $10.9 million of accounts receivable Continues to target near-term (by end of 1H 2025) profitability with existing cash and cash equivalents, anticipated growth of net product revenue, and continued reduction of manufacturing expenses Further update to be provided on Q4 2024 earnings call anticipated in late March in conjunction with Form 10-K filing WALTHAM, Mass., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced preliminary fourth quarter (Q4) financial results. Invivyd previously guided expectations to finish 2024 with $65 million or more in cash and cash equivalents and targeted near-term (by end of 1H 2025) profitability with existing cash and cash equivalents, anticipated net product revenue, and various operational efficiency improvements. With operational efficiency improvements underway, the company estimates that Invivyd ended 2024 with $69.3 million in cash and cash equivalents and $10.9 million of outstanding accounts receivable still to convert to cash, and continues to target profitability in the near-term. Based on currently available information, the company is announcing preliminary Q4 2024 PEMGARDA™ (pemivibart) net product revenue of $13.8 million, representing a 48% increase over Q3 2024 net product revenue of $9.3 million. Primarily driven by a reduction of manufacturing expenses, Invivyd is also announcing preliminary Q4 2024 total operating costs and expenses of approximately $32 million, representing a 55% reduction compared to Q3 2024 total o",url:G,image_url:a,video_url:a,publish_time:H,search_extra_info:{search_burial_info:{id:k,uid:k,ab:{scene_id:I,layer_exp:[{layer_id:J,exp_id:K}]}}},msg_id:k}}],answer_chain_name:L,agent_mode:M,native_answer:a,come_from:a,text_answer:C,trace_id:e,cost:15016,event_names:a,question:d,fallback_type:N,input_type:O,fall_back_reason:{fall_back_type:N,may_fall_back_reason:"UNKNOWN",risk_detail:{matched_words:[]}},session_id:e,first_return_cost:3665,cache_type:"no_cache",question_id:e,transfer_question:d,signal_type:"ON_COMPLETE",start_time:v,remote_svc:i,slots:[],answer_type:u,user_id:s,skill_name:w},renderList:[{type:"base_info",answer_path:"logs\u002FbaseInfo",logs:[],base_info:{trace_id:e,session_id:e,user_id:s,question:d,source:i,raw_question:d,version:"3.4.1",action_name:w,nlu:{entity:[{type:P,value:"INV.O",market:Q}]},output_time:v,deep_research:b,deep_thinking:b,agent_mode:M},extra:{}},{answer_path:l,section:{id:m,info_texts:["Thinking"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"begin"},logs:[],extra:{is_deep_research:b,deep_thinking:b}},{answer_path:l,section:{id:m,info_texts:["Querying Stock: INV Latest Report Period"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:c,status:R},logs:[],extra:{action:"Querying Stock",action_input:"INV Latest Report Period",thought:S}},{answer_path:l,section:{id:m,info_texts:["Searching Web: Why was INV Operating Expenses - Q3 2024"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:c,status:R},logs:[],extra:{action:"Searching Web",action_input:"Why was INV Operating Expenses - Q3 2024",thought:S}},{answer_path:g,section:{id:T,info_texts:[],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:g,section:{id:T,info_texts:[],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Generating Answer"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"ongoing"},logs:[],extra:{}},{answer_path:g,section:{id:y,info_texts:[],show_type:z,voice_txt:"Inv",text_answer:U,rich_text:U,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:g,section:{id:2000,info_texts:[],show_type:z,voice_txt:a,text_answer:a,rich_text:a,choice:[],result_page:{},tag_info_list:[{url:G,image_url:a,video_url:a,title:E,summary:F,index:D,publish_time:H,search_id:k,search_uid:k,search_ab:{scene_id:I,layer_exp:[{layer_id:J,exp_id:K}]},jump_type:"normal"}],is_last:c},logs:[],extra:{}},{answer_path:g,section:{id:y,info_texts:[],show_type:z,voice_txt:". This",text_answer:V,rich_text:V,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"extraInfo\u002FsourceLink",logs:[],extra:{span_id:a,link_id:a,source:a,link_text:a,link_param:a,link_ids:[]}},{answer_path:g,section:{id:1001,info_texts:[],show_type:"fenshi",choice:[],result_page:{},tag_info_list:[{stock_info:{code:"IVVD",market_id:Q,name:W,domain:P},pos:f,section_id:y,txt:W,jump_type:"pos_fenshi"}],is_last:c},logs:[],extra:{}},{answer_path:l,section:{id:m,info_texts:["Completed"],show_type:n,choice:[],result_page:{},tag_info_list:[],is_last:c,status:"end"},logs:[],extra:{}},{answer_path:"suggest\u002Fquestions",section:{id:10002,info_texts:[],show_type:"result_page",choice:[{display_text:o,query_text:o,trace_info:{item_id:"d01c7f0d27d020183ca22b3545349b8d",item_type:h,item_name:o,rec_info:X}},{display_text:p,query_text:p,trace_info:{item_id:"85173b4d741ea18af1ab3dc1cbf66f77",item_type:h,item_name:p,rec_info:Y}},{display_text:q,query_text:q,trace_info:{item_id:"9e830a479afc2606de808269fe520a47",item_type:h,item_name:q,rec_info:Z}}],result_page:{components:[{show_type:"lowcode",title_config:{show_type:"title1",data:{h1:a,h2:a},config:{display:b,txt_style:f,type:"1",display2:b,url:a}},request_config:[{source_type:_,related_name:$}],puuid:A,tag:a,category:"custom",uuid:aa}],global:{urp_static_data:[{name:$,value:{status_code:f,columns:[{type:r,index_name:ab,key:ab},{type:r,index_name:ac,key:ac},{type:r,index_name:ad,key:ad},{type:r,index_name:ae,key:ae},{type:r,index_name:af,key:af}],datas:[{send_text:o,item_type:h,rec_info:X,display_text:o,rec_reason:a},{send_text:p,item_type:h,rec_info:Y,display_text:p,rec_reason:a},{send_text:q,item_type:h,rec_info:Z,display_text:q,rec_reason:a}],dataSize:_,status_msg:a}}],lowcode_type:"shunda",interface_request_list:[],lowcode_json:{stack:b,visible:c,childLimit:9999,label:ag,type:"thslc\u002Fthslc-common-container",leaf:b,animate:[],version:"1.0.1",script:[],props:[],path:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fkernel-thslc-resource\u002Fresource\u002Fainvest\u002F0Ae514cfA4\u002Fjs\u002F_thslc-common-container_1.0.1_index.js",isTransparent:c,style:{"background-color":a,"box-shadow":"0px 0px 0px",color:a,width:t,"min-height":"100%",position:ah,height:t},isMaterial:b,id:ag,needTheme:b,hasEditor:b,packed:b,events:[],child:[{readmeUrl:"https:",stack:b,visible:c,customStyle:a,childLimit:f,label:"路径推荐",type:"iwencai\u002FrecommendList",leaf:c,version:"1.12.0",animate:[],url:B,componentUuid:aa,script:[{name:ai,id:20240320,content:"return {\r\n  created: function created() {\r\n    this.isActive = !Boolean(this.$parent.$parent.$parent.$parent.$parent.$parent.question);\r\n    var showId ='tkPanel_bottomTag';\r\n  this.buryPointId = showId;\r\n  }\r\n};"}],props:{recommendList:[],isTransparent:c,renderType:"blue"},path:B,meta:{custom_editor_url:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0editor.js",js_url:B},style:{"background-color":a,margin:"-12px 0px -12px 0px",color:a,display:"block",width:t,position:ah,height:t},isMaterial:c,_id:19,id:ai,hasEditor:c,packed:b,events:[],isSetDefaultValue:c}]}},page:{layout:{layout_data:"[{\"uuid\":\"ztxxx06c0a024223920bbbeb1e0926\",\"showType\":\"lowcode\",\"children\":[]}]"},render_for:aj,voice_txt:a,tracking_info:{},uuid:A},order:{is_auto:b,render_for:aj,chart_type:"command",puuid:A}},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"suggest\u002Finputs",section:{id:10000,info_texts:[],show_type:"choice",choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{}},{answer_path:"logs\u002Ftrace_debug",section:{id:1003,info_texts:[],show_type:x,choice:[],result_page:{},tag_info_list:[],is_last:c},logs:[],extra:{action_name:w,with_paid_index:b,no_refresh_answer:b,answer_source:{agent_id:a,agent_name:a,execute_mode:u,answer_chain_name:L},is_deep_research:b,deep_thinking:b,create_time:1746765004121},is_last:c}],questionItem:{data:{qStr:d,encodeFlag:b,imageData:j,docsData:[],quoteData:j},tplType:"question"},events:ak,agentId:a,param:{entity_info:{},add_info:{ori_question:d},event_list:ak,client_ip:a,question:d,user_id:s,user_name:a,trace_id:e,session_id:e,source:i,input_type:O}}],userId:s,userName:a,startTime:v,mobileType:a,comeFrom:a,textConstants:{},dialogContainer:j,endSignal:b,theme:"white",showTracePopup:b,traceListData:[],chatTraceTargetIndex:f,traceTableData:j,showMask:b}},serverRendered:c,routePath:"\u002Faime\u002Fshare\u002Fwhy-did-innventures-operating-expenses-surge-in-q3-2024-304c2d\u002F",config:{_app:{basePath:al,assetsPath:al,cdnURL:"\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Fiwc-aime-seo\u002F"}}}}("",false,true,"Why did InnVenture's operating expenses surge in Q3 2024?","64aa6a5a-0a36-4ee7-a8b1-67237e8bd6a4",0,"other\u002FopenAnswer","llm_generated","ths_ainvest_lite_web",null,"ff57f9044ddd0f17","progress\u002Fsearching_for",1000,"searching_for","How did InnVenture's revenue change in Q3 2024 compared to previous quarters?","Are there any recent contracts or partnerships that could explain the increase in operating expenses?","What were InnVenture's key business activities in Q3 2024?","STR","dp14504375","auto","agent",1746764989105,"explain news events","signal",2001,"rich_text","39196","\u002F\u002Fcdn.ainvest.com\u002FfrontResources\u002Fs\u002Ffoiegras\u002FrecommendList\u002F1.12.0\u002FrecommendList@1.12.0index.js","Invivyd's operating expenses did not surge in Q3 2024. In fact, the company experienced a significant reduction in its operating costs and expenses in Q4 2024, with preliminary total operating costs and expenses amounting to approximately $32 million, which represents a 55% reduction compared to the $71.6 million reported in Q3 2024. This reduction was primarily driven by a decrease in manufacturing expenses, which allowed the company to achieve a net product revenue of $13.8 million for Q4 2024, marking a 48% growth over the $9.3 million reported in Q3 2024.",2,"Invivyd Announces Preliminary Fourth Quarter 2024 ...","Primarily driven by a reduction of manufacturing expenses, Invivyd is also announcing preliminary Q4 2024 total operating costs and expenses of ...","https:\u002F\u002Finvestors.invivyd.com\u002Fnews-releases\u002Fnews-release-details\u002Finvivyd-announces-preliminary-fourth-quarter-2024-financial","2025-02-02","oeqxkhszf","oeqxkhszf_layer","base","agent_common_v2\nagent-summary","normal_agent","NONE","typewrite","stock","185","thinking","The user wants to analyze why InnVenture's operating expenses increased significantly in Q3 2024. I should focus on the latest report period to obtain the relevant data and information. I will use FinQuery for the data mentioned above; use Search for the reason behind corresponding figures; use StockNews for news of the company and market around Q3 2024.",999,"Invivyd's operating expenses did not surge in Q3 2024. In fact, the company experienced a significant reduction in its operating costs and expenses in Q4 2024, with preliminary total operating costs and expenses amounting to approximately $32 million, which represents a 55% reduction compared to the $71.6 million reported in Q3 2024[^2]",". This reduction was primarily driven by a decrease in manufacturing expenses, which allowed the company to achieve a net product revenue of $13.8 million for Q4 2024, marking a 48% growth over the $9.3 million reported in Q3 2024[^2].","Invivyd","2+679_496_21_554+0+0+64aa6a5a-0a36-4ee7-a8b1-67237e8bd6a4+d01c7f0d27d020183ca22b3545349b8d+llm_generated+aimeTagAnalysis+0+0.0033465963788330555+1","2+679_496_21_554+0+0+64aa6a5a-0a36-4ee7-a8b1-67237e8bd6a4+85173b4d741ea18af1ab3dc1cbf66f77+llm_generated+aimeTagAnalysis+0+0.0031111594289541245+2","2+679_496_21_554+0+0+64aa6a5a-0a36-4ee7-a8b1-67237e8bd6a4+9e830a479afc2606de808269fe520a47+llm_generated+aimeTagAnalysis+0+0.0021195777226239443+3",3,"recommend_query_list","ztxxx06c0a024223920bbbeb1e0926","send_text","item_type","rec_info","display_text","rec_reason","root","relative","iwencai\u002FrecommendList0326","aigc",Array(0),"\u002F"));</script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/b929a16.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/28ccbec.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/d9802b5.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/2077034.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/1e0f8d6.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/7a5f495.js" defer=""></script><script src="//cdn.ainvest.com/frontResources/s/iwc-aime-seo/921844b.js" defer=""></script>